- Home
- AXSM vs AB Comparison
AXSM vs AB Comparison
Compare AXSM & AB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- AB
- Stock Information
- Founded
- AXSM 2012
- AB 1987
- Country
- AXSM United States
- AB United States
- Employees
- AXSM N/A
- AB N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- AB Investment Managers
- Sector
- AXSM Health Care
- AB Finance
- Exchange
- AXSM Nasdaq
- AB Nasdaq
- Market Cap
- AXSM 5.1B
- AB 4.5B
- IPO Year
- AXSM 2015
- AB 1988
- Fundamental
- Price
- AXSM $108.98
- AB $41.42
- Analyst Decision
- AXSM Strong Buy
- AB Hold
- Analyst Count
- AXSM 17
- AB 5
- Target Price
- AXSM $171.65
- AB $37.40
- AVG Volume (30 Days)
- AXSM 636.2K
- AB 160.9K
- Earning Date
- AXSM 08-04-2025
- AB 07-24-2025
- Dividend Yield
- AXSM N/A
- AB 7.85%
- EPS Growth
- AXSM N/A
- AB 53.55
- EPS
- AXSM N/A
- AB 3.72
- Revenue
- AXSM $432,157,000.00
- AB N/A
- Revenue This Year
- AXSM $62.84
- AB N/A
- Revenue Next Year
- AXSM $60.02
- AB N/A
- P/E Ratio
- AXSM N/A
- AB $11.17
- Revenue Growth
- AXSM 72.16
- AB N/A
- 52 Week Low
- AXSM $72.21
- AB $30.57
- 52 Week High
- AXSM $139.13
- AB $41.99
- Technical
- Relative Strength Index (RSI)
- AXSM 56.00
- AB 57.38
- Support Level
- AXSM $102.26
- AB $40.60
- Resistance Level
- AXSM $114.66
- AB $41.79
- Average True Range (ATR)
- AXSM 3.49
- AB 0.75
- MACD
- AXSM 0.92
- AB 0.07
- Stochastic Oscillator
- AXSM 61.89
- AB 75.85
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About AB AllianceBernstein Holding L.P.
AllianceBernstein provides investment management services to institutional (41% of assets under management), retail (41%), and private (18%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of April 2025, the company had $781 billion in managed assets, composed primarily of fixed-income (38% of AUM) and equity (40%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.